MINNETONKA, Minn.--(BUSINESS WIRE)-- #AIinMedicine--AngioInsight Inc.TM, a company advancing AI-powered cardiovascular diagnostics, today announced the enrollment of the first patient in the SMARTFLOWTM clinical study, marking a significant milestone in the clinical evaluation of AngioAI+TM, the company's investigational software platform designed to assess coronary physiology from routine coronary angiographic images. SMARTFLOW represents AngioInsight's first prospective, multicenter clinical study evaluating
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
